Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Obinutuzumab biosimilar?Can liver function tests predict tigecycline's liver damage severity?How does amisulpride differ from ritalin in treating adhd?When can we anticipate xarelto's patent to expire?Is pilates compatible with lipitor use?
See the DrugPatentWatch profile for keytruda
Keytruda’s first FDA approval (in 2014) was for melanoma—specifically unresectable or metastatic melanoma. [1]
That initial FDA approval was for melanoma and came before later approvals for other tumor types (like lung cancer, bladder cancer, Hodgkin lymphoma, and others). Those are separate indications from the first approval. [1]
Other Questions About Keytruda :